Biosenta Inc. reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was CAD 0.000178 million compared to CAD 0.000175 million a year ago. Net loss was CAD 0.495068 million compared to CAD 0.33677 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.000351 million compared to CAD 0.000468 million a year ago. Net loss was CAD 0.966207 million compared to CAD 0.578613 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.03 a year ago.